{"data":[{"accessionNo":"0001172661-26-003562","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001855485","issuerName":"CALIDI BIOTHERAPEUTICS, INC.","ticker":"CLDI","cusip":"320703507","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":63391,"percentOfClass":4.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0001172661-26-003562","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001855485","issuerName":"CALIDI BIOTHERAPEUTICS, INC.","ticker":"CLDI","cusip":"320703507","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":63391,"percentOfClass":4.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0001172661-26-002136","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001855485","issuerName":"CALIDI BIOTHERAPEUTICS, INC.","ticker":"CLDI","cusip":"320703408","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":1111732,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0001172661-26-002136","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001855485","issuerName":"CALIDI BIOTHERAPEUTICS, INC.","ticker":"CLDI","cusip":"320703408","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1111732,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0002109116-26-000004","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001855485","issuerName":"Calidi Biotherapeutics, Inc.","ticker":"CLDI","cusip":"320703408","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Gavrilov Ognian Anguelov","reportingCik":"0002109116","personType":"IN","sharesOwned":20000,"percentOfClass":0.3,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0002109116-26-000003","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001855485","issuerName":"Calidi Biotherapeutics, Inc.","ticker":"CLDI","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-09","reportingPerson":"Gavrilov Ognian Anguelov","reportingCik":"0002109116","personType":"IN","sharesOwned":700000,"percentOfClass":9.8,"filedAt":"2026-03-09","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0001493152-26-005942","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001855485","issuerName":"Calidi Biotherapeutics, Inc.","ticker":"CLDI","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-18","reportingPerson":"Lincoln Alternative Strategies LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"},{"accessionNo":"0002109116-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001855485","issuerName":"Calidi Biotherapeutics, Inc.","ticker":"CLDI","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-08-20","reportingPerson":"Gavrilov Ognian Anguelov","reportingCik":null,"personType":"IN","sharesOwned":560000,"percentOfClass":7.8,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/cldi"}],"updatedAt":"2026-11-04T02:07:19.429Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cldi","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}